The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.
Open accessAbstract
BACKGROUND: The angiotensin-converting enzyme (ACE) plays an important role in the production of angiotensin II and the degradation of bradykinin, two peptides involved in cardiovascular homeostasy. Presence of a polymorphism in the ACE gene (ACE Ss) has been postulated from segregation analysis of plasma ACE in families. This putative polymorphism, which strongly affects the plasma and cellular levels of ACE, probably by modulating ACE gene transcription, has not yet been identified at the molecular level; however, an insertion/deletion polymorphism is present in the 16th intron of the ACE gene (ACE I/D) and appears to be a very good marker for ACE Ss. The biological role of ACE suggests that the ACE gene polymorphism could affect the predisposition to myocardial infarction (MI). METHODS AND RESULTS: We have recently shown, in a large case-control study (ECTIM), that the marker allele D of the ACE gene, which is associated with higher levels of ACE in plasma and cells, was more frequent in male patients with MI than in control subjects, especially in patients considered at low risk. ACE activity has now been measured from frozen aliquots of plasma in a large subsample of the ECTIM study (n = 1086). Plasma ACE level did not differ between patients and control subjects in the older age group (> or = 55 years) but was higher in patients than in control subjects in the younger age group (< 55 years); P < .005 after adjustment on ACE I/D and other risk factors. In patients, plasma ACE levels decreased with age (R = -.225, P < 10(-4)), but in control subjects no such trend was observed. In the low-risk group (ApoB < 1.25 mg/dL, body mass index < 26 kg/m2, and not treated with hypolipidemic drugs), plasma ACE level was increased in patients when compared with control subjects among homozygotes and heterozygotes for the ACE I allele (P < .015). Analysis of the distribution of plasma ACE by using commingling analysis conditional on the marker genotype ACE I/D enabled us to infer the frequencies and effects of the postulated ACE Ss genotypes. The results suggest that the higher plasma ACE levels in patients than in control subjects in the younger age group were due to a difference in frequency of the postulated S allele (.47 versus .36). CONCLUSIONS: These results extend our previous findings and indicate that plasma ACE level may be a risk factor for MI, independent of the ACE I/D polymorphism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Self-citationTwo putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.
Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G., & Corvol, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9386 · Cited by 750
Costerousse, O., Allegrini, J., Lopez, M., & Alhenc-Gelas, F. (1993) · Biochemical Journal · doi:10.1042/bj2900033 · Cited by 507
Self-citationSkewness in Commingled Distributions
Maclean, C. J., Morton, N. E., Elston, R. C., & Yee, S. (1976) · Biometrics · doi:10.2307/2529760 · Cited by 326
Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.
Cambien, F., Alhenc‐Gelas, F., Herbeth, B., André, J.-L., Rakotovao, R., Gonzales, M. F., Allegrini, J., & Bloch, C. (1988) · PubMed · Cited by 278
Self-citationTiret, L., Nicaud, V., Kee, F., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Amouyel, P., Poirier, O., Lecerf, L., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91075-w · Cited by 254
Self-citationAlhenc‐Gelas, F., Richard, J. L., Courbon, D., Warnet, J., & Corvol, P. L. (1991) · PubMed · Cited by 182
Rigat, B. A., Hübert, C., Corvol, P. L., & Soubrier, F. (1992) · Cited by 75
Larochelle, P. M., Genest, J., Kuchel, O., Boucher, R., Gutkowska, Y., & Mckinstry, D. (1979) · PubMed Central · Cited by 47
Induction of Angiotensin I-Converting Enzyme by Captopril in Cultured Human Endothelial Cells*
Fyhrquist, F., Hortling, L., & Grönhagen‐Riska, C. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-4-783 · Cited by 36
Cited by
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854
Schieffer, B., Schieffer, E., Hilfiker-Kleiner, D., Hilfiker, A., Kovanen, P. T., Kaartinen, M., Nussberger, J., Harringer, W., & Drexler, H. (2000) · Circulation · doi:10.1161/01.cir.101.12.1372 · Cited by 654
O’Donnell, C. J., Lindpaintner, K., Larson, M. G., Rao, V. S., Ordovas, J. M., Schaefer, E. J., Myers, R. H., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.97.18.1766 · Cited by 551
Staessen, J. A., Wang, J. G., Ginocchio, G., Petrov, V., Saavedra, A. P., Soubrier, F., Vlietinck, R., & Fagard, R. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715120-00059 · Cited by 385
Metadata
- Authors
- Cambien, F., Costerousse, O., Tiret, L., Poirier, O., Lecerf, L., Gonzales, M. F., Evans, A., Arveiler, D., Cambou, J. P., & Luc, G.
- Venue
- Circulation
- Published
- 1994-08
- Volume
- 90
- Issue
- 2
- Pages
- 669-676
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2063042541
- Cited by
- 260
- References
- 10
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. https://app.cochat.ai/papers/10.1161/01.cir.90.2.669
- The paper
- Cambien, F., Costerousse, O., Tiret, L., Poirier, O., Lecerf, L., Gonzales, M. F., Evans, A., Arveiler, D., Cambou, J. P., & Luc, G. (1994). Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. https://doi.org/10.1161/01.cir.90.2.669
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.